Assessment of the efficacy of 0.1% cyclosporine A cationic emulsion in the treatment of dry eye disease during COVID-19 pandemic

Objective: To assess the efficacy of 0.1% cyclosporine A (CsA) cationic emulsion (CE) in the treatment of dry eye disease (DED) in terms of ocular surface disease index (OSDI). Methods: DED patients with corneal fluorescein staining grade (CFS) ≤ 3 on the Oxford scale and Schirmer test score < 10...

Descripción completa

Detalles Bibliográficos
Autor principal: Stopyra, Wiktor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Romanian Society of Ophthalmology 2023
Materias:
General Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385704/
https://www.ncbi.nlm.nih.gov/pubmed/37522012
http://dx.doi.org/10.22336/rjo.2023.28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385704/
https://www.ncbi.nlm.nih.gov/pubmed/37522012
http://dx.doi.org/10.22336/rjo.2023.28

Ejemplares similares